The GMDN Agency has a Board of Trustees.
John Wilkinson, OBE, is Director of Devices at the MHRA which he joined in 2012 and he served as Chair of the Executive Group of the European Competent Authority Network between 2014 and 2018. Prior to joining the MHRA, John was Chief Executive of Eucomed, the European medical technology industry association.
His earlier experience included the role of Director General of the Association of British Healthcare Industries and a number of roles in the medical devices industry, both in the UK and the USA, with Becton Dickinson and the BOC Group. These were followed by a period as Chief Executive of an early stage medical imaging company.
John holds a first degree in Zoology from the University of Aberdeen and an MBA from the University of Warwick.
He was awarded an OBE for services to the medical devices industry in the 2010 New Year’s honours list.
Dr Elizabeth D. Krell is retired from a career at the US FDA’s Center for Devices and Radiological Health (CDRH) where she served as the CDRH Deputy Director for Science, as well as Acting Senior Science Advisor to the FDA Commissioner, and Director of FDA’s Office of Science Coordination and Communication. She is a past Director of CDRH’s Office of Science and Technology, predecessor to the Office of Science and Engineering Laboratories, and past Chair of the Global Harmonization Task Force.
Dr. Krell served as Executive Vice President for Technology and Regulatory Affairs for AdvaMed and is a current or past member of a number of medical device-related boards as well as those for non-profit community organizations.
Dr. Christina Tong is currently with the National University of Singapore advising Professors and Researchers in Translational Activities from Research to Commercialisation. She previously held positions as Group Director at the Health Sciences Authority of Singapore responsible for the Group’s Regulatory Activities in Drugs, Medical Devices, and other Health Care Products; as well as Senior Vice President in Vertex Management, a venture capital management company in the Singapore Technologies Group. She was also on the Board of a number of technology and biotech start-ups in US, Europe and Asia.
Janet E. Trunzo is Senior Advisor to the President and Senior Executive Vice President, Technology and Regulatory Affairs, for the Advanced Medical Technology Association (AdvaMed) and leads a team of regulatory experts.
During her tenure at AdvaMed, she has focused on the passage of the Medical Device User Fee and Modernization Act of 2002 and subsequent updates. She also concentrates on global regulatory harmonisation and representing the U.S. device industry on the Global Harmonization Task Force. She also chairs the Regulatory Committee for the Global Medical Technology Alliance.
Previously Janet held positions at Hybritech, Inc., a medical device and diagnostics manufacturer, and Scripps Clinic and Research Foundation, a hospital, diagnostic clinic and research institute.
Deniz joined the agency in November 2022. Specialising in strategic planning and implementation with medical devices, pharmaceuticals, and biologics, Deniz has a proven track record of delivering challenging targets and change management, in addition to the vital skills needed to drive forward our strategy focusing on external stakeholder engagement and patient safety. She has an Economy degree from Hacettepe University.
Mark joined the GMDN Agency at the start of 2010 and served as the CEO till November 2022. He is a Chartered Engineer and Member of the IET. Mark has an MSc in Engineering from Cranfield University.
During his time, the Agency has increased membership from 400 to over 5,000 manufacturers and regulators in over 120 countries. Mark has been to every continent promoting the adoption and use of the GMDN to support regulation as the single harmonised system for device naming and grouping of medical devices.
Mark previously worked as the International Projects manager at the British Standards Institution and as a Senior Engineer at Instron Ltd.